@avidresearch@dedwng Maybe comment on how they plann to disclose the data.. sounds like they are saving the details for later which might not instill confidence to some
@monaco_biotech Interesting.. I thought FDA couldn't accept new filings during govt shutdown during FY26.. perhaps there are still enough carryover fees to review?